Literature DB >> 23297661

Strategies and resources to address colorectal cancer screening rates and disparities in the United States and globally.

Michael B Potter1.   

Abstract

Colorectal cancer is a significant cause of mortality in the United States and globally. In the United States, increased access to screening and effective treatment has contributed to a reduction in colorectal cancer incidence and mortality for the general population, though significant disparities persist. Worldwide, the disparities are even more pronounced, with vastly different colorectal cancer mortality rates and trends among nations. Newly organized colorectal cancer screening programs in economically developed countries with a high burden of colorectal cancer may provide pathways to reduce these disparities over time. This article provides an overview of colorectal cancer incidence, mortality, screening, and disparities in the United States and other world populations. Promising strategies and resources are identified to address colorectal cancer screening rates and disparities in the United States and worldwide.

Entities:  

Mesh:

Year:  2013        PMID: 23297661     DOI: 10.1146/annurev-publhealth-031912-114436

Source DB:  PubMed          Journal:  Annu Rev Public Health        ISSN: 0163-7525            Impact factor:   21.981


  17 in total

Review 1.  The utility of metabolomics in natural product and biomarker characterization.

Authors:  Daniel G Cox; Joonseok Oh; Adam Keasling; Kim L Colson; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2014-08-20

2.  SAV1 represses the development of human colorectal cancer by regulating the Akt-mTOR pathway in a YAP-dependent manner.

Authors:  Jianwu Jiang; Wei Chang; Yang Fu; Yongshun Gao; Chunlin Zhao; Xiefu Zhang; Shuijun Zhang
Journal:  Cell Prolif       Date:  2017-06-15       Impact factor: 6.831

3.  Clinical retrospective study on the expression of the PD-L1 molecule in sporadic colorectal cancer and its correlation with K-ras gene mutations in Chinese patients.

Authors:  Jiasheng Xu; Wenpeng Zhao; Kaili Liao; Luxia Tu; Xiaozhen Jiang; Hua Dai; Yanqing Yu; Qiuying Xiong; Zhenfang Xiong
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

4.  The impact of colorectal screening program on the detection of right-sided colorectal cancer. A 5-year cohort study in the Mantua District.

Authors:  Corrado R Asteria; Salvatore Pucciarelli; Leonardo Gerard; Nicola Mantovani; Mauro Pagani; Luigi Boccia; Paolo Ricci; Luigi Troiano; Giuseppe Lucchini; Coriolano Pulica
Journal:  Int J Colorectal Dis       Date:  2015-08-09       Impact factor: 2.571

Review 5.  Colorectal cancer in Saudi Arabia as the proof-of-principle model for implementing strategies of predictive, preventive, and personalized medicine in healthcare.

Authors:  Mesnad Alyabsi; Abdulrahman Alhumaid; Haafiz Allah-Bakhsh; Mohammed Alkelya; Mohammad Azhar Aziz
Journal:  EPMA J       Date:  2019-08-31       Impact factor: 6.543

Review 6.  Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT).

Authors:  James E Allison; Callum G Fraser; Stephen P Halloran; Graeme P Young
Journal:  Gut Liver       Date:  2014-03-11       Impact factor: 4.519

Review 7.  Reducing inequities in colorectal cancer screening in North America.

Authors:  Kathleen M Decker; Harminder Singh
Journal:  J Carcinog       Date:  2014-11-14

Review 8.  Development of a Group-Based Community Health Worker Intervention to Increase Colorectal Cancer Screening Among Latinos.

Authors:  C L De La Torre; J N Dumbauld; J Haughton; S Gupta; J Nodora; R Espinoza Giacinto; C Ramers; B Bharti; K Wells; J Lopez; M Díaz; J Moody; Elva M Arredondo
Journal:  Hisp Health Care Int       Date:  2020-05-29

9.  Deregulation of the replisome factor MCMBP prompts oncogenesis in colorectal carcinomas through chromosomal instability.

Authors:  Mauricio Quimbaya; Eric Raspé; Geertrui Denecker; Bram De Craene; Ria Roelandt; Wim Declercq; Xavier Sagaert; Lieven De Veylder; Geert Berx
Journal:  Neoplasia       Date:  2014-09       Impact factor: 5.715

10.  A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia.

Authors:  Erin L Symonds; Susanne K Pedersen; Rohan T Baker; David H Murray; Snigdha Gaur; Stephen R Cole; Geetha Gopalsamy; Dileep Mangira; Lawrence C LaPointe; Graeme P Young
Journal:  Clin Transl Gastroenterol       Date:  2016-01-14       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.